HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism.

AbstractOBJECTIVE:
To evaluate the usefulness of B-type natriuretic peptide and troponin I measurements in predicting right ventricular dysfunction (RVD) in non-massive pulmonary embolism.
DESIGN:
Prospective observational study.
SETTING:
University-affiliated emergency unit, cardiology and pneumology departments.
PATIENTS:
Sixty-seven patients admitted because of acute pulmonary embolism, without shock on admission, completed the study.
INTERVENTIONS:
Blood samples and echocardiography were obtained on admission for subsequent and independent assessment of B-type natriuretic peptide (BNP) and troponin I levels as well as RVD.
MEASUREMENTS AND RESULTS:
Echocardiographic RVD was diagnosed in 36 patients and was severe in 13 on admission. BNP and troponin I levels were higher in patients with RVD than in those with no RVD [62 (27-105) vs. 431 (289-556) pg/ml for BNP, p<0.001; 0.01 (0-0.09) vs. 0.16 (0.03-0.32) microg/l for troponin I, p=0.005]. The area under the receiving operating characteristic curve (AUC) for diagnosing RVD was 0.93 for BNP and 0.72 for troponin I. The troponin I level increased further when RVD was severe, compared with moderate, and the AUC was 0.91 for identifying severe RVD. Diagnoses of RVD and severe RVD were ruled out by BNP<or=100 pg/ml (30% of patients) and troponin I 0.10 microg/l (58% of patients), respectively. In-hospital death or circulatory failure occurred in nine patients; all had echographic RVD and level of BNP >100 pg/ml and troponin I >0.10 microg/l.
CONCLUSION:
In hemodynamically stable pulmonary embolism, BNP/troponin I measurement is helpful on admission, especially for ruling out RVD, i.e. patients with in-hospital high-risk.
AuthorsDamien Logeart, Lucien Lecuyer, Gabriel Thabut, Jean-Yves Tabet, Jean-Michel Tartière, Christophe Chavelas, François Bonnin, Jean-Louis Stievenart, Alain Cohen Solal
JournalIntensive care medicine (Intensive Care Med) Vol. 33 Issue 2 Pg. 286-92 (Feb 2007) ISSN: 0342-4642 [Print] United States
PMID17165016 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Natriuretic Peptides
  • Troponin
  • Natriuretic Peptide, Brain
Topics
  • Aged
  • Biomarkers
  • Female
  • Humans
  • Male
  • Middle Aged
  • Natriuretic Peptide, Brain (blood)
  • Natriuretic Peptides (blood)
  • Prospective Studies
  • Pulmonary Embolism (blood, complications)
  • ROC Curve
  • Severity of Illness Index
  • Troponin (blood)
  • Ultrasonography
  • Ventricular Dysfunction, Right (blood, complications, diagnostic imaging)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: